Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Michael S. Oh's publication output changed over time?
ScholarIQpublication output · 2012–2025
Output grew0% over the shown period — from 1 works in 2012 to 1 in 2025.
1
1
1
1
3
2
1
1
20122015201720182019202020242025
What are the most-cited papers on Michael S. Oh?
ScholarIQmost cited works
The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane
Jeremy M. Baskin, Xudong Wu, Romain Christiano, Michael S. Oh, Curtis Schauder, Elisabetta Gazzerro, Mirko Messa, Sımona Baldassari, Stefania Assereto, Roberta Biancheri, Federico Zara, Carlo Minetti, Andrea Raimondi, Mikael Simons, Tobias C. Walther, Karin M. Reinisch, Pietro De Camilli
S151741590. 2015155 CitationsOPEN ACCESS
Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions
Young Kwang Chae, Michael S. Oh
Journal of Thoracic Oncology. 2018147 Citations
Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity
Poulomi Sengupta, Sudipta Basu, Shivani Soni, Ambarish Pandey, Bhaskar Roy, Michael S. Oh, Kenneth T. Chin, Abhimanyu S. Paraskar, Sasmit Sarangi, Yamicia Connor, Venkata Sabbisetti, Jawahar Kopparam, Ashish Kulkarni, Katherine W. Muto, Chitra Amarasiriwardena, Innocent Jayawardene, Nicola Lupoli, Daniela M. Dinulescu, Joseph V. Bonventre, R. A. Mashelkar, Shiladitya Sengupta
Proceedings of the National Academy of Sciences. 2012135 CitationsOPEN ACCESS
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer
Raymond J. Lim, Ramin Salehi‐Rad, Linh M. Tran, Michael S. Oh, Camelia Dumitras, William P. Crosson, Rui Li, Tejas S. Patel, Samantha Man, Cara E. Yean, Jensen Abascal, ZiLing Huang, Stephanie L. Ong, Kostyantyn Krysan, Steven M. Dubinett, Bin Liu
Cell Reports Medicine. 2024120 CitationsOPEN ACCESS
Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating <i>RET</i> Alterations and Oncogenic Signaling Pathway Aberrations
Thereasa A. Rich, Karen L. Reckamp, Young Kwang Chae, Robert C. Doebele, Wade T. Iams, Michael S. Oh, Victoria M. Raymond, Richard B. Lanman, Jonathan W. Riess, Thomas E. Stinchcombe, Vivek Subbiah, David R. Trevarthen, Stephen R. Fairclough, Jennifer Yen, Oliver Gautschi
Clinical Cancer Research. 201991 CitationsOPEN ACCESS
Related on ScholarIQ
APLA Health
Institution
The leukodystrophy protein FAM126A (hyccin) regulates PtdIns(4)P synthesis at the plasma membrane
Paper
Detection of Minimal Residual Disease Using ctDNA in Lung Cancer: Current Evidence and Future Directions
Paper
Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity
Paper
CXCL9/10-engineered dendritic cells promote T cell activation and enhance immune checkpoint blockade for lung cancer
Paper
Analysis of Cell-Free DNA from 32,989 Advanced Cancers Reveals Novel Co-occurring Activating <i>RET</i> Alterations and Oncogenic Signaling Pathway Aberrations
Paper